NCT02153567View on ClinicalTrials.gov

SSRI Study for Functional Dyspepsia (SS)

PHASE3CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

December 6, 2013

Primary Completion Date

December 31, 2018

Study Completion Date

January 9, 2019

Conditions
DyspepsiaAnxietyDepression
Interventions
DRUG

Escitalopram

Escitalopram 5mg daily will be given for the first 2 weeks and then Escitalopram 10mg daily will be given for the next 8 weeks.

OTHER

Placebo

Placebo will be given for the next 10 weeks.

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT02153567 - SSRI Study for Functional Dyspepsia (SS) | Biotech Hunter | Biotech Hunter